BDBM66295 1-(2-chlorobenzyl)-2-esyl-benzimidazole::1-[(2-chlorophenyl)methyl]-2-ethylsulfonyl-benzimidazole::1-[(2-chlorophenyl)methyl]-2-ethylsulfonylbenzimidazole::MLS000115085::SMR000092317::cid_940252

SMILES Cc1ncc(COc2ccc3oc(C)c(C(=O)N[C@@H](CO)C(N)=O)c3c2)s1

InChI Key InChIKey=JICNGQWIIRKMMM-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 66295   

TargetTransient receptor potential cation channel subfamily M member 3(Mouse)
Katholieke Universiteit Leuven

US Patent
LigandChemical structure of BindingDB Monomer ID 66295BDBM66295(BHV-2100 | US12209081, Compound 453-En-1)
Affinity DataIC50: 1.00E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute (TS...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2026
Entry Details
US Patent